Clinuvel Pharmaceuticals Limited (ASX:CUV)
Australia · Delayed Price · Currency is AUD 9.56
-0.15 (-1.54%)
Aug 12, 2026, 3:14 PM AEST
Clinuvel Pharmaceuticals Financials Overview
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Revenue Revenue Growth | 96.3 | 95.02 | 88.18 | 78.32 | 65.72 | 48.32 |
Revenue Growth | 1.35% | 7.76% | 12.58% | 19.17% | 36.02% | 48.37% |
Gross Profit Gross Profit Growth | 86.32 | 86.54 | 80.45 | 70.8 | 56.47 | 44.15 |
Operating Income Operating Income Growth | 43 | 45.76 | 48.57 | 44.13 | 35.55 | 28.57 |
Net Income Net Income Growth | 32.54 | 36.17 | 35.64 | 30.6 | 20.88 | 24.73 |
Earnings Per Share EPS Growth | 0.64 | 0.72 | 0.70 | 0.59 | 0.40 | 0.48 |
EPS Growth | -10.35% | 2.86% | 18.11% | 46.65% | -16.74% | 62.42% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Switzerland and Others Switzerland and Others Growth | 8.3 | 6.7 | 6.04 | 5.58 | 5.23 |
Europe & USA Excl. Switzerland Europe & USA Excl. Switzerland Growth | 86.72 | 81.48 | 72.28 | - | - |
Total Total Growth | 95.02 | 88.18 | 78.32 | 65.72 | 47.98 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Investments Cash & Investments Growth | 233 | 224.11 | 183.87 | 156.81 | 121.51 | 82.69 |
Total Debt Total Debt Growth | 0.32 | 0.53 | 0.88 | 1 | 1.26 | 1.3 |
Net Cash (Debt) Net Cash Growth | 232.68 | 223.58 | 182.99 | 155.81 | 120.25 | 81.39 |
Net Cash Growth | 4.07% | 22.18% | 17.44% | 29.57% | 47.75% | 24.39% |
Net Cash Per Share Net Cash Per Share Growth | 4.60 | 4.44 | 3.59 | 3.01 | 2.32 | 1.59 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 40.47 | 41.1 | 37.05 | 36.91 | 39.87 | 19.26 |
Capital Expenditures CapEx Growth | -0.39 | -0.3 | -5.58 | -1.03 | -0.43 | -0.85 |
Free Cash Flow Free Cash Flow Growth | 40.08 | 40.8 | 31.48 | 35.88 | 39.44 | 18.41 |
Free Cash Flow Growth | -1.76% | 29.61% | -12.28% | -9.01% | 114.25% | 38.41% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Gross Margin | 89.63% | 91.08% | 91.23% | 90.40% | 85.92% | 91.36% |
Operating Margin | 44.65% | 48.16% | 55.08% | 56.34% | 54.09% | 59.12% |
Pretax Margin | 45.90% | 54.26% | 57.47% | 58.19% | 52.22% | 53.22% |
Profit Margin | 33.79% | 38.07% | 40.41% | 39.08% | 31.77% | 51.18% |
FCF Margin | 41.62% | 42.94% | 35.70% | 45.82% | 60.01% | 38.10% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 12, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.050 | 0.050 | 0.050 | 0.050 | 0.040 | 0.025 |
Dividend Per Share Growth | 0% | 0% | 0% | 25.00% | 60.00% | 0% |
Dividend Yield | 0.52% | 0.48% | 0.33% | 0.28% | 0.27% | 0.08% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 12, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | 15.09 | 14.38 | 21.60 | 28.87 | 35.14 | 61.34 |
Forward PE | 13.23 | 13.16 | 21.49 | 28.34 | 26.11 | 78.02 |
P/FCF Ratio | 12.22 | 12.75 | 24.46 | 24.62 | 18.61 | 82.41 |
PS Ratio | 5.08 | 5.48 | 8.73 | 11.28 | 11.16 | 31.39 |